InsidersTradesSigma
Track the Lotus Eye Hospital stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €2.4bn. The latest transaction was filed on 3 June 2026 (Acquisition). Among the most active insiders: Sangeetha Sundaramoorthy. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Lotus Eye Hospital es un centro médico especializado en el cuidado de los ojos. Ofrece una gama de servicios, desde exámenes de la vista hasta intervenciones quirúrgicas.